IL143833A0 - Aciclovir compositions containing dimethicone - Google Patents

Aciclovir compositions containing dimethicone

Info

Publication number
IL143833A0
IL143833A0 IL14383399A IL14383399A IL143833A0 IL 143833 A0 IL143833 A0 IL 143833A0 IL 14383399 A IL14383399 A IL 14383399A IL 14383399 A IL14383399 A IL 14383399A IL 143833 A0 IL143833 A0 IL 143833A0
Authority
IL
Israel
Prior art keywords
aciclovir
compositions containing
containing dimethicone
dimethicone
compositions
Prior art date
Application number
IL14383399A
Other languages
English (en)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10845017&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL143833(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IL143833A0 publication Critical patent/IL143833A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL14383399A 1998-12-23 1999-12-21 Aciclovir compositions containing dimethicone IL143833A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9828620.6A GB9828620D0 (en) 1998-12-23 1998-12-23 Medicaments
PCT/EP1999/010155 WO2000038695A2 (en) 1998-12-23 1999-12-21 Aciclovir compositions containing dimethicone

Publications (1)

Publication Number Publication Date
IL143833A0 true IL143833A0 (en) 2002-04-21

Family

ID=10845017

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14383399A IL143833A0 (en) 1998-12-23 1999-12-21 Aciclovir compositions containing dimethicone
IL143833A IL143833A (en) 1998-12-23 2001-06-19 Acyclvir preparations containing demeticon

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL143833A IL143833A (en) 1998-12-23 2001-06-19 Acyclvir preparations containing demeticon

Country Status (27)

Country Link
EP (1) EP1140117B1 (zh)
JP (1) JP4145493B2 (zh)
KR (1) KR100707329B1 (zh)
CN (2) CN100415237C (zh)
AR (1) AR021993A1 (zh)
AT (1) ATE236644T1 (zh)
AU (1) AU768989B2 (zh)
BR (1) BR9916524A (zh)
CA (1) CA2356895A1 (zh)
CZ (1) CZ295770B6 (zh)
DE (2) DE69906796T2 (zh)
DK (1) DK1140117T3 (zh)
ES (1) ES2196910T3 (zh)
GB (2) GB9828620D0 (zh)
HK (2) HK1039275A1 (zh)
HU (1) HU230542B1 (zh)
IL (2) IL143833A0 (zh)
NO (1) NO322090B1 (zh)
NZ (1) NZ512457A (zh)
PE (1) PE20001351A1 (zh)
PL (1) PL196629B1 (zh)
PT (1) PT1140117E (zh)
SI (1) SI1140117T1 (zh)
TR (1) TR200102482T2 (zh)
TW (1) TW585768B (zh)
WO (1) WO2000038695A2 (zh)
ZA (1) ZA200105071B (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2005824A1 (de) † 2007-06-21 2008-12-24 Bayer CropScience AG Wirkstoffsuspensionen in Glycerin
CN102256602A (zh) * 2008-10-21 2011-11-23 诺沃德米克斯国际有限公司 用于治疗上皮组织的组合物
WO2012107573A1 (en) * 2011-02-10 2012-08-16 Moberg Derma Ab Novel formulations for dermal, transdermal and mucosal use 3
WO2015082172A1 (en) * 2013-12-03 2015-06-11 Zzip Ag Polydimethylsiloxane for the treatment of viral infections

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2080106B (en) * 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations
KR900015739A (ko) * 1989-04-24 1990-11-10 히비히 폰 모르쯔 비이온성 계면활성제를 함유하는 국소 치료용 항바이러스성 제약 조성물
GB9114939D0 (en) * 1991-07-11 1991-08-28 Smithkline Beecham Plc Pharmaceutical formulation
FR2728167A1 (fr) * 1994-12-15 1996-06-21 Cird Galderma Composition cosmetique ou dermatologique sous forme d'une emulsion eau dans huile a teneur elevee en hydroxyacides
FR2737118B1 (fr) * 1995-07-28 1997-09-05 Oreal Composition dermatologique ou pharmaceutique, procede de preparation et utilisation

Also Published As

Publication number Publication date
AU2099700A (en) 2000-07-31
HK1067548A1 (en) 2005-04-15
SI1140117T1 (en) 2003-12-31
GB2362105B (en) 2003-06-18
BR9916524A (pt) 2001-10-02
ATE236644T1 (de) 2003-04-15
CN100415237C (zh) 2008-09-03
WO2000038695A3 (en) 2000-10-26
HUP0104594A2 (en) 2002-06-29
CZ20012332A3 (cs) 2001-12-12
PL196629B1 (pl) 2008-01-31
CN1334737A (zh) 2002-02-06
ZA200105071B (en) 2002-09-20
EP1140117B1 (en) 2003-04-09
DE69906796D1 (de) 2003-05-15
GB2362105A (en) 2001-11-14
AU768989B2 (en) 2004-01-15
EP1140117A2 (en) 2001-10-10
DK1140117T3 (da) 2003-07-21
GB9828620D0 (en) 1999-02-17
JP2002542149A (ja) 2002-12-10
JP4145493B2 (ja) 2008-09-03
NO20013103L (no) 2001-08-20
HU230542B1 (hu) 2016-11-28
NO322090B1 (no) 2006-08-14
KR20010099932A (ko) 2001-11-09
CN1191834C (zh) 2005-03-09
PE20001351A1 (es) 2000-12-14
KR100707329B1 (ko) 2007-04-13
WO2000038695A2 (en) 2000-07-06
CZ295770B6 (cs) 2005-11-16
IL143833A (en) 2006-12-31
HK1039275A1 (zh) 2002-04-19
CN1539421A (zh) 2004-10-27
HUP0104594A3 (en) 2002-12-28
TW585768B (en) 2004-05-01
DE29924428U1 (de) 2003-08-28
TR200102482T2 (tr) 2003-03-21
ES2196910T3 (es) 2003-12-16
GB0117795D0 (en) 2001-09-12
AR021993A1 (es) 2002-09-04
DE69906796T2 (de) 2004-01-29
PT1140117E (pt) 2003-08-29
CA2356895A1 (en) 2000-07-06
NO20013103D0 (no) 2001-06-21
NZ512457A (en) 2003-10-31
PL349505A1 (en) 2002-07-29

Similar Documents

Publication Publication Date Title
PL341372A1 (en) Cellecoxibe containing compositions
GB9804720D0 (en) Shampoo compositions
PL343552A1 (en) Shampoo compositions
GB9822518D0 (en) Antiperspirant compositions
GB9804725D0 (en) Shampoo compositions
PL343892A1 (en) Mousse-forming shampoo compositions
HU9901606D0 (en) Pharmaceutical compositions
PL347941A1 (en) Shampoo compositions
HUP0103507A3 (en) Pharmaceutical compositions comprising 2-quinolones
PL343627A1 (en) Medicinal compositions
PL334568A1 (en) Paroxetin containing compositions
GB9726970D0 (en) Shampoo compositions
PL338922A1 (en) Oral compositions
IL142534A0 (en) Pharmaceutical compositions containing an antigen-adjuvent
GB9812819D0 (en) Dentifrice compositions
GB2362105B (en) Aciclovir compositions containing dimethicone
AP2000001878A0 (en) Pharmaceutical compositions
GB9818123D0 (en) Cosmetic compositions
GB9818016D0 (en) Cosmetic compositions
GB9806487D0 (en) Pharmaceutical compositions
HU9803024D0 (en) Oral compositions containing ubidekarenone
PL330972A1 (en) Tetrahydrolypstatin containing compositions
GB9804717D0 (en) Shampoo compositions
GB9801091D0 (en) Actinide/non-actinide compositions
GB9705844D0 (en) Oral prophyllactic compositions

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed